Bertrand Tuan in San Francisco, California

Home California San Francisco

Bertrand Tuan has Hematology/oncology as his primary medical specialty. Their primary office is: 2100 Webster St in San Francisco, California.

They're a part of the: Pacific Hematology Oncology Assoc. medical group which has around 3 members. You can call their office at 415-923-3012 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Albert Einstein College Of Medicine Of Yeshiva University and graduated in 1985 (around 39 years of experience). They are listed as doing telehealth appointments.

Bertrand Y Tuan Office Phone and Directions

Bertrand Tuan
Pacific Hematology Oncology Assoc.
2100 Webster St
San Francisco, California 94115
415-923-3012

Patient Ratings
Please rate your experience with Bertrand Tuan below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 415-923-3012

Enter a starting address:

Healthcare Info for Bertrand Tuan

Medical School: Albert Einstein College Of Medicine Of Yeshiva University
Graduation Year: 1985
The Primary Medical Specialty for Bertrand Tuan is listed as: Hematology/oncology
Approximate Years of Experience: 39
PAC (PECOS ID)#: 9234298811
NPI #: 1578632980
NPI Created On: 11/07/2006
NPI Last Updated Listed as: 07/08/2007
Primary Taxonomy Code: 174400000X
License Number:
G78339
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish.

Services and Procedures include:

Insertion of needle into vein for collection of blood sample
Diagnostic bone marrow aspiration
Bone marrow biopsy
Complete blood cell count (red cells, white blood cell, platelets), automated test
Hydration infusion into a vein 31 minutes to 1 hour
Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
Injection of drug or substance into a vein for therapy, diagnosis, or prevention
Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
Infusion of chemotherapy into a vein up to 1 hour
Infusion of chemotherapy into a vein
Infusion of different chemotherapy drug or substance into a vein up to 1 hour
Therapeutic removal of whole blood to correct blood level imbalance
New patient office or other outpatient visit, typically 45 minutes
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 5 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $6

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788406645

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $5

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788406649

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788406653

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788406657

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Payments Total: $3

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788406661

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Payments Total: $24

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788406665

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Payments Total: $3

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788406669

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $10

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788406673

Being Disputed:: No

Product Related: No

Payments Total: $450

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 788406677

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 782545473

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Hematology/oncology Professionals in San Francisco

1.
Jennifer Michlitsch

400 Parnassus Ave
San-francisco, CA
Ucsf Medical Group Business Services

2.
Julia Chu

505 Parnassus Ave
San-francisco, CA
Ucsf Pediatrics Associates

3.
Jahan Tavakoli MD

2200 Ofarrell St
San-francisco, CA
Permanente Medical Group Inc

4.
Jahan Tavakoli MD

2238 Geary Blvd
San-francisco, CA
Permanente Medical Group Inc

5.
Tilak Sundaresan

2238 Geary Blvd
San-francisco, CA
Permanente Medical Group Inc

6.
Vinayak Prasad

1001 Potrero Ave
San-francisco, CA
University Of California Sfgh Medical Group

Providers in Pacific Hematology Oncology Assoc.

1.Ari Baron

2100 Webster St
San Francisco Ca 94115-2376
Pacific Hematology Oncology Assoc.
Hematology/oncology

2.Caroline Behler Md

2100 Webster St
San Francisco Ca 94115-2376
Pacific Hematology Oncology Assoc.
Hematology/oncology

3.Bertrand Tuan

2100 Webster St
San Francisco Ca 94115-2376
Pacific Hematology Oncology Assoc.
Hematology/oncology

View all 3 members of Pacific Hematology Oncology Assoc. medical group